ResearcherCentral South UniversityNo recent work listed

Guo‐Huang Hu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5063969005. Sources: OpenAlex.

Their work

Papers: 5 (first author 4, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 5

Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer. First author DOI 10.1016/j.pan.2018.08.011 ↗
Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s12253-015-9930-y ↗
Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1. First author DOI 10.4149/neo_2014_020 ↗
MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. First author DOI 10.1007/s12253-013-9637-x ↗
GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer. Last author DOI 10.1016/j.asjsur.2012.08.001 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kemin Wu · 2 shared papers, 2013–2015 · strength 0.10
- Paper Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12253-015-9930-y ↗
- Paper MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. DOI 10.1007/s12253-013-9637-x ↗
Weijia Sun · 2 shared papers, 2013–2015 · strength 0.10
- Paper Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12253-015-9930-y ↗
- Paper MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. DOI 10.1007/s12253-013-9637-x ↗
JieFeng Liu · 1 shared paper, 2018 · strength 0.08
- Paper Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer. DOI 10.1016/j.pan.2018.08.011 ↗
Yiping Liu · 1 shared paper, 2018 · strength 0.08
- Paper Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer. DOI 10.1016/j.pan.2018.08.011 ↗
Kun Song · 1 shared paper, 2015 · strength 0.06
- Paper Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12253-015-9930-y ↗
Jian Li · 1 shared paper, 2015 · strength 0.06
- Paper Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12253-015-9930-y ↗
Juan Li · 1 shared paper, 2014 · strength 0.05
- Paper Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1. DOI 10.4149/neo_2014_020 ↗
Weijia Sun · 1 shared paper, 2014 · strength 0.05
- Paper Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1. DOI 10.4149/neo_2014_020 ↗
Lian Duan · 1 shared paper, 2013 · strength 0.05
- Paper GPC-1 may serve as a predictor of perineural invasion and a prognosticator of survival in pancreatic cancer. DOI 10.1016/j.asjsur.2012.08.001 ↗
Jian Li · 1 shared paper, 2013 · strength 0.04
- Paper MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer. DOI 10.1007/s12253-013-9637-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.